114 related articles for article (PubMed ID: 32207186)
21. [Small renal masses: 10 years of treatment in a tertiary referral center in cancer research].
Broucqsault A; Ouzzane A; Leroy X; Lemaitre L; Zini L
Prog Urol; 2012 Oct; 22(12):692-700. PubMed ID: 22999115
[TBL] [Abstract][Full Text] [Related]
22. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
Sorbellini M; Kattan MW; Snyder ME; Reuter V; Motzer R; Goetzl M; McKiernan J; Russo P
J Urol; 2005 Jan; 173(1):48-51. PubMed ID: 15592023
[TBL] [Abstract][Full Text] [Related]
23. Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis - a multi-institutional study from LARCG database.
Mourão TC; Abreu D; Carvalhal GF; Gueglio G; da Costa WH; Calsavara VF; Meza-Montoya L; Bengió RG; Scorticati C; Castillejos-Molina R; Rodríguez-Covarrubias F; Autran-Gómez AM; Campos-Salcedo JG; Nolazco A; Ameri C; Zampolli H; Langenhin R; Muguruza D; Machado MT; Mingote P; Clavijo J; Nogueira L; Clark O; Rovegno AR; Secin FP; Decia R; Guimarães GC; Glina S; Rodríguez-Faba O; Palou J; Zequi SC
BMC Urol; 2020 Jul; 20(1):85. PubMed ID: 32615971
[TBL] [Abstract][Full Text] [Related]
24. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
25. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
[TBL] [Abstract][Full Text] [Related]
26. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.
Wood EL; Adibi M; Qiao W; Brandt J; Zhang M; Tamboli P; Matin SF; Wood CG; Karam JA
J Urol; 2018 Feb; 199(2):393-400. PubMed ID: 28941919
[TBL] [Abstract][Full Text] [Related]
27. Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses.
Ayangbesan A; Golombos DM; Golan R; O'Malley P; Lewicki P; Wu X; Scherr DS
J Endourol; 2019 Jan; 33(1):50-60. PubMed ID: 29914269
[TBL] [Abstract][Full Text] [Related]
28. The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy.
Zhou L; Chang Y; Xu L; Liu Z; Fu Q; Yang Y; Lin Z; Xu J
J Urol; 2016 Aug; 196(2):335-42. PubMed ID: 26970566
[TBL] [Abstract][Full Text] [Related]
29. Postoperative prognostic model for patients with clear cell renal cell carcinoma in a Chinese population.
Zhu Y; Zhao YR; Yang XF; Wei MT; Niu YJ; Chang JW; Wang AX; Liang X
Int J Urol; 2019 Jun; 26(6):624-629. PubMed ID: 30861595
[TBL] [Abstract][Full Text] [Related]
30. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
[TBL] [Abstract][Full Text] [Related]
31. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
32. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
33. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
34. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic radical nephrectomy for large renal masses: critical assessment of perioperative and oncologic outcomes of stage T2a and T2b tumors.
Pierorazio PM; Hyams ES; Lin BM; Mullins JK; Allaf ME
Urology; 2012 Mar; 79(3):570-5. PubMed ID: 22386399
[TBL] [Abstract][Full Text] [Related]
36. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
[TBL] [Abstract][Full Text] [Related]
37. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
[TBL] [Abstract][Full Text] [Related]
38. Imaging strategy and outcome following partial nephrectomy.
Mouracade P; Chavali JS; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Rini BI; Kaouk JH
Urol Oncol; 2017 Nov; 35(11):660.e1-660.e8. PubMed ID: 28863862
[TBL] [Abstract][Full Text] [Related]
39. Bilateral renal cancers: oncological and functional outcomes.
Berczi C; Thomas B; Bacso Z; Flasko T
Int Urol Nephrol; 2016 Oct; 48(10):1617-22. PubMed ID: 27379623
[TBL] [Abstract][Full Text] [Related]
40. Primary tumor size in renal cell cancer in relation to the occurrence of synchronous metastatic disease.
Zastrow S; Phuong A; von Bar I; Novotny V; Hakenberg OW; Wirth MP
Urol Int; 2014; 92(4):462-7. PubMed ID: 24642839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
